Modeling Juvenile Dermatomyositis with Engineered Human Skeletal Muscle: Effects of Type I Interferonβ and Janus Kinase Inhibitors
Conferences
Covert, L; Truskey, G; Dvergsten, J
Published in: ARTHRITIS & RHEUMATOLOGY
September 2022
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
ARTHRITIS & RHEUMATOLOGY
EISSN
2326-5205
ISSN
2326-5191
Publication Date
September 2022
Volume
74
Start / End Page
61 / 64
Related Subject Headings
- 3204 Immunology
- 3202 Clinical sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Covert, L., Truskey, G., & Dvergsten, J. (2022). Modeling Juvenile Dermatomyositis with Engineered Human Skeletal Muscle: Effects of Type I Interferonβ and Janus Kinase Inhibitors. In ARTHRITIS & RHEUMATOLOGY (Vol. 74, pp. 61–64).
Covert, Lauren, George Truskey, and Jeffrey Dvergsten. “Modeling Juvenile Dermatomyositis with Engineered Human Skeletal Muscle: Effects of Type I Interferonβ and Janus Kinase Inhibitors.” In ARTHRITIS & RHEUMATOLOGY, 74:61–64, 2022.
Covert L, Truskey G, Dvergsten J. Modeling Juvenile Dermatomyositis with Engineered Human Skeletal Muscle: Effects of Type I Interferonβ and Janus Kinase Inhibitors. In: ARTHRITIS & RHEUMATOLOGY. 2022. p. 61–4.
Covert, Lauren, et al. “Modeling Juvenile Dermatomyositis with Engineered Human Skeletal Muscle: Effects of Type I Interferonβ and Janus Kinase Inhibitors.” ARTHRITIS & RHEUMATOLOGY, vol. 74, 2022, pp. 61–64.
Covert L, Truskey G, Dvergsten J. Modeling Juvenile Dermatomyositis with Engineered Human Skeletal Muscle: Effects of Type I Interferonβ and Janus Kinase Inhibitors. ARTHRITIS & RHEUMATOLOGY. 2022. p. 61–64.
Published In
ARTHRITIS & RHEUMATOLOGY
EISSN
2326-5205
ISSN
2326-5191
Publication Date
September 2022
Volume
74
Start / End Page
61 / 64
Related Subject Headings
- 3204 Immunology
- 3202 Clinical sciences